Madrigal Pharmaceuticals Inc

MDGL NASDAQ Santé & Biotech États-Unis US5588681057
499.76 $
3.95 %

Madrigal Pharmaceuticals se concentre sur le développement de thérapies pour traiter les maladies cardio-métaboliques, notamment la stéatose hépatique.

Performance & Momentum

6 Months 9.88 %
1 Year 75.32 %
3 Years 104.74 %
5 Years 375.01 %

Similar stocks to Madrigal Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Madrigal Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases